Lim JSJ, Wong ALA, Ow SGW, Ngoi NYL, et al. Phase Ib/II dose expansion study of lenvatinib combined with letrozole in post-menopausal women with hormone receptor positive breast cancer. Clin Cancer Res 2022 Apr 1. pii: 694118. doi: 10.1158/1078-0432.CCR-21-4179.
PMID: 35363275